Syneos Says Not Currently in Talks on Potential LabCorp Deal
This article is for subscribers only.
Syneos Health Inc. said it’s not currently in talks on a deal with Laboratory Corp. of America Holdings, although the company continues to study ways to boost shareholder value.
Bloomberg News reported last week that the companies were discussing a transaction in which part of Labcorp’s Covance clinical research division would merge with Syneos. Shares of Syneos jumped 4.5% in premarket trading Monday in New York, while Labcorp shares gained 3.2%.